118 related articles for article (PubMed ID: 15229955)
21. Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy.
Nishida H; Ishida H; Tanaka T; Amano H; Omoto K; Shirakawa H; Shimizu T; Iida S; Toki D; Yamaguchi Y; Tanabe K
Transpl Int; 2009 Oct; 22(10):961-9. PubMed ID: 19619177
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.
Avetisyan G; Aschan J; Hägglund H; Ringdén O; Ljungman P
Bone Marrow Transplant; 2007 Nov; 40(9):865-9. PubMed ID: 17724444
[TBL] [Abstract][Full Text] [Related]
23. Detection of herpesvirus DNAs in perilymph obtained from patients with sensorineural hearing loss by real-time polymerase chain reaction.
Sugiura S; Yoshikawa T; Nishiyama Y; Morishita Y; Sato E; Beppu R; Hattori T; Nakashima T
Laryngoscope; 2004 Dec; 114(12):2235-8. PubMed ID: 15564852
[TBL] [Abstract][Full Text] [Related]
24. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
[TBL] [Abstract][Full Text] [Related]
25. [Prognosis value of the pp65 antigenemia and semi-quantitative PCR in the detection of the CMV reactivation in bone marrow grafted patients].
Ksouri H; Lakhal A; Ben Amor R; Torjman L; Achour W; Ben Othmen T; Ladeb S; Abdelkefi A; Slim A; Abdeladhim A; Ben Hassen A
Bull Soc Pathol Exot; 2006 Jul; 99(3):155-9. PubMed ID: 16983816
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
[TBL] [Abstract][Full Text] [Related]
27. A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection.
Humar A; Kumar D; Gray M; Moussa G; Venkataraman S; Kumar R; Tipples GA
Transplantation; 2007 May; 83(9):1200-6. PubMed ID: 17496536
[TBL] [Abstract][Full Text] [Related]
28. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
[TBL] [Abstract][Full Text] [Related]
29. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
Pumannova M; Roubalova K; Vitek A; Sajdova J
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
[TBL] [Abstract][Full Text] [Related]
30. Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia.
Yoda Y; Hanaoka R; Ide H; Isozaki T; Matsunawa M; Yajima N; Shiozawa F; Miwa Y; Negishi M; Kasama T
Mod Rheumatol; 2006; 16(3):137-42. PubMed ID: 16767551
[TBL] [Abstract][Full Text] [Related]
31. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
[TBL] [Abstract][Full Text] [Related]
32. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
33. Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR.
Madi N; Al-Nakib W; Mustafa AS; Saeed T; Pacsa A; Nampoory MR
Med Princ Pract; 2007; 16(4):268-73. PubMed ID: 17541291
[TBL] [Abstract][Full Text] [Related]
34. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
[TBL] [Abstract][Full Text] [Related]
36. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
[TBL] [Abstract][Full Text] [Related]
37. [Quantitative real-time PCR--usefulness in detection and monitoring of CMV infection after hematopeietic stem cells transplant].
Grabarczyk P; Brojer E; Nasiłowska B; Mariańska B
Pol Merkur Lekarski; 2006 Sep; 21(123):227-31. PubMed ID: 17163182
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.
Koehl U; Dirkwinkel E; Koenig M; Erben S; Soerensen J; Bader P; Doerr HW; Preiser W; Weissinger E; Klingebiel T; Martin H; Lehrnbecher T
Klin Padiatr; 2008; 220(6):348-52. PubMed ID: 18949669
[TBL] [Abstract][Full Text] [Related]
39. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
[TBL] [Abstract][Full Text] [Related]
40. Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Vaessen N; Claas EC; Barge RM; Kroes AC
Bone Marrow Transplant; 2007 Jul; 40(2):137-43. PubMed ID: 17530007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
